Search

everythinglearnresearchcommunity

for

Search:↓

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Psychological factors play a significant role in developing alopecia areata.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

Overweight women with PCOS are more likely to have excess male hormones.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Women with acne and hair loss, even if they have regular periods, often have polycystic ovary syndrome.

Acanthosis nigricans in teenage girls with PCOS is a sign of obesity, not insulin resistance or glucose intolerance.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

A woman's severe male-like symptoms were caused by a rare, benign tumor in her ovary that produced male hormones.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.